-
Loading metrics
The host-directed therapeutic imatinib mesylate accelerates immune responses to Mycobacterium marinum infection and limits pathology associated with granulomas
- Tesia L. Cleverley,
- Siri Peddineni,
- Jeannette Guarner,
- Francesca Cingolani,
- Pamela K. Garcia,
- Heather Koehler,
- Edward S. Mocarski,
- Daniel Kalman
x
-
- Published: May 18, 2023
- https://doi.org/10.1371/journal.ppat.1011387